Startup Basics

Most founders wait too long to file a trademark. Not because they don’t care. But because there’s always something louder pulling their attention: the product build, the first customers, hiring, runway, demos, investor calls. The problem is simple: your brand is not just a logo. It is the name people remember. It is the word […]

When you are raising venture capital, your name matters more than most founders expect. It is not just a logo. It is not just a domain. Your company name becomes a shortcut in an investor’s head. It shows up in pitch decks, group chats, term sheets, press releases, and customer emails. If that name is

Freedom to Operate: When You Need It looks at your startup, they are not only looking at your product or your team. They are also looking at what you own. Not in an ego way. In a legal and business way. Because if you build something that works, someone will copy it. And if you

Picture this: you finally get a meeting with the exact buyer you want. They’re curious. They’re leaning in. And right when the talk starts to feel real, you say the words that can freeze the room: “Before I share anything, I need you to sign an NDA.” Sometimes that’s the right move. Many times, it

AI teams move fast. Code ships. Models change. People copy small bits of text into a prompt and move on. That speed is exciting. It is also where IP contamination sneaks in. IP contamination is when your product, model, or code base quietly absorbs someone else’s protected work in a way that can later hurt

Dual licensing sounds clean on paper. You ship code under one license for the community, and you sell a second license to companies that want fewer limits. In one move, you can grow fast and still keep a path to real revenue. But dual licensing is also a trap if you set it up the

Most founders think VC due diligence is about revenue, growth, and product. It is. But for technical startups, there is another quiet deal-breaker that shows up fast once lawyers and security teams get involved: open source compliance. If your code uses open source (and it almost always does), investors will want to know one thing:

Most founders wait too long to think about patents. Not because they do not care. But because building the product feels urgent. Hiring feels urgent. Shipping feels urgent. Patents feel like paperwork for later. Then a seed investor asks one question that changes the mood in the room: “What’s defensible here?” If you do not

Provisional patents get talked about like they are a magic shield. File one, and investors will instantly take you seriously. Your startup is “protected.” Your pitch gets stronger. Your round gets easier. Sometimes that is true. But just as often, a provisional patent does almost nothing for fundraising. Worse, it can quietly hurt you if

Most founders wait too long to think about protection. They build fast, ship code, share decks, post demos, and only then realize: “Wait… what do we actually own that a bigger team can’t copy?” This is where the “patents vs trade secrets” question shows up. Not as a theory class. As a real, painful moment.